Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons

A hallmark of glioblastoma multiforme (GBM) is neoangiogenesis, mediated by the overexpression of vascular endothelial growth factor (VEGF). Anti-VEGF antibodies, like bevacizumab, prolong progression-free survival in GBM, however, this treatment has been reported to be associated with a decline in...

Descripción completa

Detalles Bibliográficos
Autores principales: Latzer, Pauline, Shchyglo, Olena, Hartl, Tim, Matschke, Veronika, Schlegel, Uwe, Manahan-Vaughan, Denise, Theiss, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445260/
https://www.ncbi.nlm.nih.gov/pubmed/30971896
http://dx.doi.org/10.3389/fncel.2019.00113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445260/
https://www.ncbi.nlm.nih.gov/pubmed/30971896
http://dx.doi.org/10.3389/fncel.2019.00113

Ejemplares similares